Literature DB >> 8252222

Experience with laparoscopic colorectal surgery for malignant disease.

P J Guillou1, A Darzi, J R Monson.   

Abstract

Laparoscopic or laparoscopic-assisted surgery for colorectal cancer was attempted in 59 patients suffering from malignant disease of the anus, rectum and colon over a 20-month period. Conversion to open surgery was necessary in 5 patients (8.4%). The peroperative (30-day) mortality was 5.8%, and in two of the three patients who died this was attributable to thrombo-embolic complications. The cancer-related mortality was 8%. There were 5 Dukes' A, 21 Dukes' B and 25 Dukes' C lesions resected, and thus far all recurrences were in patients who had Dukes' C lesions. The resection margins and lymph node yield in these specimens were similar to those achieved with conventional open surgery. Six patients also had hepatic metastases recognized at the time of primary surgery. These preliminary data indicate the feasibility of performing laparoscopic-assisted resection of colorectal cancer without compromising the accepted principles of excisional surgery for malignant disease. However, a number of important issues such as thrombo-embolic prophylaxis, specimen retrieval and the long-term recurrence rates require further study before these procedures are widely adopted for colorectal cancer.

Entities:  

Mesh:

Year:  1993        PMID: 8252222     DOI: 10.1016/0960-7404(93)90058-7

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  14 in total

1.  Clinical outcome of laparoscopic and open colectomy for right colonic carcinoma.

Authors:  J S Khan; A K Hemandas; K G Flashman; A Senapati; D O'Leary; A Parvaiz
Journal:  Ann R Coll Surg Engl       Date:  2011-11       Impact factor: 1.891

2.  Laparoscopic colorectal surgery: analysis of 140 cases.

Authors:  S D Wexner; P Reissman; J Pfeifer; M Bernstein; N Geron
Journal:  Surg Endosc       Date:  1996-02       Impact factor: 4.584

Review 3.  Laparoscopic surgery for benign and malign diseases of the digestive system: indications, limitations, and evidence.

Authors:  Markus Alexander Küper; Friederike Eisner; Alfred Königsrainer; Jörg Glatzle
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

4.  Laparoscopic-assisted resection of colorectal malignancies: a systematic review.

Authors:  A E Chapman; M D Levitt; P Hewett; R Woods; H Sheiner; G J Maddern
Journal:  Ann Surg       Date:  2001-11       Impact factor: 12.969

Review 5.  Laparoscopic surgery for diseases of the colon and rectum--quo vadis?

Authors:  P J Guillou
Journal:  Surg Endosc       Date:  1994-06       Impact factor: 4.584

Review 6.  Trocar site recurrence in laparoscopic surgery for colorectal cancer.

Authors:  O Zmora; P Gervaz; S D Wexner
Journal:  Surg Endosc       Date:  2001-06-12       Impact factor: 4.584

7.  Laparoscopic colectomy for colon cancer: comparable to conventional oncologic surgery?

Authors:  Ricardo M Bonnor; Kirk A Ludwig
Journal:  Clin Colon Rectal Surg       Date:  2005-08

8.  Minimally invasive surgery for colorectal cancer. Initial follow-up.

Authors:  G C Hoffman; J W Baker; J B Doxey; G W Hubbard; W K Ruffin; J A Wishner
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

Review 9.  Laparoscopic resection of colon Cancer: consensus of the European Association of Endoscopic Surgery (EAES).

Authors:  R Veldkamp; M Gholghesaei; H J Bonjer; D W Meijer; M Buunen; J Jeekel; B Anderberg; M A Cuesta; A Cuschierl; A Fingerhut; J W Fleshman; P J Guillou; E Haglind; J Himpens; C A Jacobi; J J Jakimowicz; F Koeckerling; A M Lacy; E Lezoche; J R Monson; M Morino; E Neugebauer; S D Wexner; R L Whelan
Journal:  Surg Endosc       Date:  2004-06-23       Impact factor: 4.584

10.  Short-term outcome analysis of a randomized study comparing laparoscopic vs open colectomy for colon cancer.

Authors:  A M Lacy; J C García-Valdecasas; J M Piqué; S Delgado; E Campo; J M Bordas; P Taurá; L Grande; J Fuster; J L Pacheco
Journal:  Surg Endosc       Date:  1995-10       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.